720 related articles for article (PubMed ID: 33760889)
1. Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry.
Ren W; Zhu Y; Wang Y; Shi H; Yu Y; Hu G; Feng F; Zhao X; Lan J; Wu J; Kenney DJ; Douam F; Tong Y; Zhong J; Xie Y; Wang X; Yuan Z; Zhou D; Zhang R; Ding Q
PLoS Pathog; 2021 Mar; 17(3):e1009392. PubMed ID: 33760889
[TBL] [Abstract][Full Text] [Related]
2. Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage.
Shukla N; Roelle SM; Snell JC; DelSignore O; Bruchez AM; Matreyek KA
PLoS Pathog; 2024 May; 20(5):e1012044. PubMed ID: 38768238
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic analysis reveals varying levels of mammalian adaptation to coronavirus infections.
King SB; Singh M
PLoS Comput Biol; 2021 Nov; 17(11):e1009560. PubMed ID: 34793437
[TBL] [Abstract][Full Text] [Related]
4. Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis.
Zeiss CJ; Compton S; Veenhuis RT
ILAR J; 2021 Dec; 62(1-2):35-47. PubMed ID: 33836527
[TBL] [Abstract][Full Text] [Related]
5. Experimental Inoculation of Young Calves with SARS-CoV-2.
Falkenberg S; Buckley A; Laverack M; Martins M; Palmer MV; Lager K; Diel DG
Viruses; 2021 Mar; 13(3):. PubMed ID: 33803455
[TBL] [Abstract][Full Text] [Related]
6. Cell entry by SARS-CoV-2.
Peng R; Wu LA; Wang Q; Qi J; Gao GF
Trends Biochem Sci; 2021 Oct; 46(10):848-860. PubMed ID: 34187722
[TBL] [Abstract][Full Text] [Related]
7. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.
Shilts J; Crozier TWM; Greenwood EJD; Lehner PJ; Wright GJ
Sci Rep; 2021 Jan; 11(1):413. PubMed ID: 33432067
[TBL] [Abstract][Full Text] [Related]
8. Exogenous Chemicals Impact Virus Receptor Gene Transcription: Insights from Deep Learning.
Liu X; Guo Y; Pan W; Xue Q; Fu J; Qu G; Zhang A
Environ Sci Technol; 2023 Nov; 57(46):18038-18047. PubMed ID: 37186679
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural insight into SARS-CoV-2 entry and budding in human airway epithelium.
Pinto AL; Rai RK; Brown JC; Griffin P; Edgar JR; Shah A; Singanayagam A; Hogg C; Barclay WS; Futter CE; Burgoyne T
Nat Commun; 2022 Mar; 13(1):1609. PubMed ID: 35338134
[TBL] [Abstract][Full Text] [Related]
10. Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2.
Brady M; McQuaid C; Solorzano A; Johnson A; Combs A; Venkatraman C; Rahman A; Leyva H; Kwok WE; Wood RW; Deane R
Commun Biol; 2021 Nov; 4(1):1318. PubMed ID: 34811493
[TBL] [Abstract][Full Text] [Related]
11. Semantic and Population Analysis of the Genetic Targets Related to COVID-19 and Its Association with Genes and Diseases.
Papageorgiou L; Papakonstantinou E; Diakou I; Pierouli K; Dragoumani K; Bacopoulou F; Chrousos GP; Eliopoulos E; Vlachakis D
Adv Exp Med Biol; 2023; 1423():59-78. PubMed ID: 37525033
[TBL] [Abstract][Full Text] [Related]
12. The panzootic potential of SARS-CoV-2.
Mabry ME; Fanelli A; Mavian C; Lorusso A; Manes C; Soltis PS; Capua I
Bioscience; 2023 Nov; 73(11):814-829. PubMed ID: 38125826
[TBL] [Abstract][Full Text] [Related]
13. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations.
Cao Y; Li L; Feng Z; Wan S; Huang P; Sun X; Wen F; Huang X; Ning G; Wang W
Cell Discov; 2020; 6():11. PubMed ID: 32133153
[No Abstract] [Full Text] [Related]
14. Correction to: Genetic Landscape of the ACE2 Coronavirus Receptor.
Circulation; 2022 Jul; 146(1):e4. PubMed ID: 35858169
[No Abstract] [Full Text] [Related]
15. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
McCallum M; De Marco A; Lempp FA; Tortorici MA; Pinto D; Walls AC; Beltramello M; Chen A; Liu Z; Zatta F; Zepeda S; di Iulio J; Bowen JE; Montiel-Ruiz M; Zhou J; Rosen LE; Bianchi S; Guarino B; Fregni CS; Abdelnabi R; Foo SC; Rothlauf PW; Bloyet LM; Benigni F; Cameroni E; Neyts J; Riva A; Snell G; Telenti A; Whelan SPJ; Virgin HW; Corti D; Pizzuto MS; Veesler D
Cell; 2021 Apr; 184(9):2332-2347.e16. PubMed ID: 33761326
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.
Planas D; Bruel T; Grzelak L; Guivel-Benhassine F; Staropoli I; Porrot F; Planchais C; Buchrieser J; Rajah MM; Bishop E; Albert M; Donati F; Prot M; Behillil S; Enouf V; Maquart M; Smati-Lafarge M; Varon E; Schortgen F; Yahyaoui L; Gonzalez M; De Sèze J; Péré H; Veyer D; Sève A; Simon-Lorière E; Fafi-Kremer S; Stefic K; Mouquet H; Hocqueloux L; van der Werf S; Prazuck T; Schwartz O
Nat Med; 2021 May; 27(5):917-924. PubMed ID: 33772244
[TBL] [Abstract][Full Text] [Related]
17. Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model.
Kurup D; Malherbe DC; Wirblich C; Lambert R; Ronk AJ; Zabihi Diba L; Bukreyev A; Schnell MJ
PLoS Pathog; 2021 Mar; 17(3):e1009383. PubMed ID: 33765062
[TBL] [Abstract][Full Text] [Related]
18. New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
Abdool Karim SS; de Oliveira T
N Engl J Med; 2021 May; 384(19):1866-1868. PubMed ID: 33761203
[No Abstract] [Full Text] [Related]
19. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
Hoffmann M; Arora P; Groß R; Seidel A; Hörnich BF; Hahn AS; Krüger N; Graichen L; Hofmann-Winkler H; Kempf A; Winkler MS; Schulz S; Jäck HM; Jahrsdörfer B; Schrezenmeier H; Müller M; Kleger A; Münch J; Pöhlmann S
Cell; 2021 Apr; 184(9):2384-2393.e12. PubMed ID: 33794143
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.
Zhao MM; Yang WL; Yang FY; Zhang L; Huang WJ; Hou W; Fan CF; Jin RH; Feng YM; Wang YC; Yang JK
Signal Transduct Target Ther; 2021 Mar; 6(1):134. PubMed ID: 33774649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
